Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthesis

Making Ibuprofen In Three Minutes

by Bethany Halford
December 15, 2014 | A version of this story appeared in Volume 92, Issue 50

In less time than it takes most people to check out at a drugstore, David R. Snead and Timothy F. Jamison can whip up the popular nonsteroidal anti-inflammatory drug ibuprofen. The MIT chemists report that by using continuous-flow processing, they are able to synthesize the compound in three minutes from basic building blocks (Angew. Chem. Int. Ed. 2014, DOI: 10.1002/anie.201409093). The synthesis demonstrates that continuous-flow procedures can handle extreme conditions and produce large quantities of active pharmaceutical ingredients without using massive reactors. In fact, the synthesis makes use of a harsh Friedel-Crafts acylation, employs the aggressive oxidant iodine monochloride, and the whole thing takes place in a reactor that’s about half the size of a standard lab fume hood. The five-stage process, which includes three bond-forming steps, one workup, and one liquid-liquid separation, produces about 8 g of ibuprofen in an hour. Snead and Jamison write that they were inspired by a 2009 continuous-flow ibuprofen synthesis from D. Tyler McQuade’s group at Florida State University. McQuade tells C&EN that the MIT effort shows that continuous-flow synthesis is “the future of chemical processing.”

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.